![William K. Holstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William K. Holstein
Geen lopende functies
Profiel
William K.
Holstein worked as a Senior Vice President of Business Development at Gemmus Pharma, Inc..
Mr. Holstein attended The University of Colorado where he earned an undergraduate degree.
Eerdere bekende functies van William K. Holstein
Bedrijven | Functie | Einde |
---|---|---|
Gemmus Pharma, Inc.
![]() Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Financieel Directeur/CFO | - |
Opleiding van William K. Holstein
The University of Colorado | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Gemmus Pharma, Inc.
![]() Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Health Technology |